VOYA Investment Management
HUMA icon

VOYA Investment Management’s Humacyte HUMA Stock Holding History

VOYA Investment Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2K Hold
26,772
– – ﹤0.01% 2339
2025
Q4 		$25.7K Buy
26,772
+4,976
+23% +$7.05K ﹤0.01% 2390
2025
Q3 		$37.9K Sell
21,796
-12,445
-36% -$24.4K ﹤0.01% 2405
2025
Q2 		$71.6K Buy
34,241
+9,327
+37% +$17.9K ﹤0.01% 2548
2025
Q1 		$42.5K Sell
24,914
-1,377
-5% -$5.17K ﹤0.01% 2569
2024
Q4 		$133K Sell
26,291
-3,038
-10% -$15K ﹤0.01% 2506
2024
Q3 		$160K Sell
29,329
-341
-1% -$2.25K ﹤0.01% 2545
2024
Q2 		$142K Buy
29,670
+9,582
+48% +$49.9K ﹤0.01% 2578
2024
Q1 		$62.5K Sell
20,088
-6,194
-24% -$20.8K ﹤0.01% 2705
2023
Q4 		$74.6K Hold
26,282
– – ﹤0.01% 2802
2023
Q3 		$77K Buy
26,282
+1,382
+6% +$4.57K ﹤0.01% 2789
2023
Q2 		$71.2K Buy
24,900
+3,726
+18% +$13.4K ﹤0.01% 2866
2023
Q1 		$65.4K Hold
21,174
– – ﹤0.01% 2761
2022
Q4 		$44.7K Buy
+21,174
New +$64.3K ﹤0.01% 2861

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VOYA Investment Management's HUMA Position: Q1 2026 in Review

VOYA Investment Management held its Humacyte (HUMA) position steady in Q1 2026 at 26,772 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

VOYA Investment Management first reported a position in HUMA in Q4 2022 and has held it in 14 quarters since. The position peaked at $160K in Q3 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • VOYA Investment Management held 26,772 shares of Humacyte worth $16.2K as of Q1 2026.
  • VOYA Investment Management left its Humacyte share count unchanged in Q1 2026.
  • Humacyte made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2339 holding.
  • VOYA Investment Management first reported a position in Humacyte in Q4 2022 and has held it in 14 quarters since.
  • VOYA Investment Management's Humacyte position peaked at $160K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.